Synergistic effect of sequential administration of mitoguazone (MGBG) and gemcitabine in treating tissue cultured human breast cancer cells and mammary rat tumors.

about

Synergistic effect of sequential administration of mitoguazone (MGBG) and gemcitabine in treating tissue cultured human breast cancer cells and mammary rat tumors.

Item

http://www.wikidata.org/entity/Q44439083

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Synergistic effect of sequenti ...... cells and mammary rat tumors.

@en

Synergistic effect of sequential administration of mitoguazone

@nl

type

Item

label

Synergistic effect of sequenti ...... cells and mammary rat tumors.

@en

Synergistic effect of sequential administration of mitoguazone

@nl

prefLabel

Synergistic effect of sequenti ...... cells and mammary rat tumors.

@en

Synergistic effect of sequential administration of mitoguazone

@nl

P1476

Synergistic effect of sequenti ...... cells and mammary rat tumors.

@en

P2093

D Richard Ishmael

http://www.w3.org/2001/XMLSchema#string

Hong Liu

http://www.w3.org/2001/XMLSchema#string

John A Nordquist

http://www.w3.org/2001/XMLSchema#string

Robert E Nordquist

http://www.w3.org/2001/XMLSchema#string

Wei R Chen

http://www.w3.org/2001/XMLSchema#string

P2860

A phase I clinical, plasma, and cellular pharmacology study of gemcitabine

Phase II study of weekly gemcitabine in patients with metastatic breast cancer relapsing or failing both an anthracycline and a taxane.

Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: a multicenter phase II trial. Greek Breast Cancer Cooperative Group.

Weekly docetaxel plus gemcitabine or vinorelbine in refractory advanced breast cancer patients: a parallel dose-finding study. Southern Italy Cooperative Oncology Group (SICOG).

Gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed breast cancer patients.

Gemcitabine and vinorelbine in pretreated advanced breast cancer: a pilot study.

Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: a phase II study conducted by the Hellenic Cooperative Oncology Group.

Phase I study of stealth liposomal doxorubicin in combination with gemcitabine in the treatment of patients with metastatic breast cancer.

Unexpected severe myelotoxicity of gemcitabine in pretreated breast cancer patients.

Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) in previously treated ovarian cancer patients.

P304

217-226

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1081/CNV-120016418

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2003-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12743987

http://www.w3.org/2001/XMLSchema#string

P921

gemcitabine